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for any disease or pathological condition 
by an optometrist who meets specified 
requirements. The bill would establish a 
seven-member pharmaceutical advisory 
committee with a prescribed membership 
to provide advice to the Board as to the use 
of diagnostic and therapeutic agents. 
Under this bill, only optometrists who 
meet several examination and training re-
quirements and agree to accept Medi-Cal 
patients are permitted to use, dispense, or 
prescribe therapeutic pharmaceutical 
agents. AB 2020 would also make it a 
misdemeanor for any person licensed as 
an optometrist to refer a patient to a phar-
macy that is owned by the licensee or in 
which the licensee has a proprietary inter-
est. This bill, which sponsored by the Cal-
ifornia Optometric Association and is op-
posed by the California Medical Associa-
tion, was rejected on June 28 but was 
granted reconsideration. [S. B&PJ 
SB 908 (Calderon), as introduced 
March 4, would provide that the terms 
"license" and "certificate of registration" 
are deemed to be synonymous for the pur-
poses of the provisions of law regarding 
the Ii censure and regulation of optometry. 
[A. Health} 
SB 921 (Maddy), as introduced March 
4, would provide that it is unprofessional 
conduct for an optometrist to fail to advise 
a patient in writing of any pathology that 
requires the attention of a physician when 
an examination of the eyes indicates a 
substantial likelihood of any pathology. 
[S. B&PJ 
■ LITIGATION 
On May 12, in California Optometric 
Association (COA) v. Division of Allied 
Health Professions, Medical Board of 
California, No. 531542, and Engineers 
and Scientists of California (ESC), et al. 
v. Division of Allied Health Professions, 
Medical Board of California, No. 
532588, the Sacramento County Superior 
Court approved the parties' stipulation to 
consolidate the two cases; £SC was desig-
nated as the lead case. In this matter, ESC 
and COA challenge the validity of the 
medical assistant regulations adopted by 
the Medical Board's Division of Allied 
Health Professions, contending that the 
regulations permit unlicensed medical as-
sistants to perform optometric tasks and 
functions. At this writing, a trial-setting 
conference is scheduled for December 6. 
[ 13:2&3 CRLR JOO] 
■ RECENT MEETINGS 
At the Board's May 20-21 meeting, 
DCA legal counsel Robert Miller com-
mented on Business and Professions Code 
section 651, which authorizes optome-
trists and other professionals to state in 
advertisements that they are certified in a 
particular area of expertise by a private or 
public board or agency or that they limit 
their practice to a particular area of exper-
tise. Miller noted that the Board has the 
authority to allow an optometrist to adver-
tise a certification only after it has ap-
proved or recognized the private or public 
board, agency, or other parent organiza-
tion that is providing certification. Miller 
also noted that a recent U.S. Supreme 
Court ruling provides states with the right 
to limit such advertising if its use is mis-
leading to the public, but prohibits states 
from infringing on an individual's right to 
engage in truthful, non-misleading adver-
tising or to list certifications by bona fide 
organizations in advertising. 
At the Board's August 12-13 meeting, 
staff announced that the occupational 
analysis of the practice of optometry is 
expected to be completed by December. 
[ 13: I CRLR 59} Staff also noted that the 
Board's licensure examination was given 
July 15-18 at the UC Berkeley School of 
Optometry; the application fee was $275, 
which represented a $200 increase over 
prior years. 
■ FUTURE MEETINGS 
December 1-2 in Orange County. 
BOARD OF PHARMACY 
Executive Officer: Patricia Harris 
(916) 445-5014 
Pursuant to Business and Professions Code section 4000 et seq., the Board 
of Pharmacy grants licenses and permits 
to pharmacists, pharmacies, drug manu-
facturers, wholesalers, and sellers of hy-
podermic needles. It regulates all sales of 
dangerous drugs, controlled substances, 
and poisons. The Board is authorized to 
adopt regulations, which are codified in 
Division 17, Title 16 of the California 
Code of Regulations (CCR). To enforce its 
regulations, the Board employs full-time 
inspectors who investigate complaints re-
ceived by the Board. Investigations may 
be conducted openly or covertly as the 
situation demands. 
The Board conducts fact-finding and 
disciplinary hearings and is authorized by 
law to suspend or revoke licenses or per-
mits for a variety of reasons, including 
professional misconduct and any acts sub-
stantially related to the practice of phar-
macy. 
The Board consists of ten members, 
three of whom are nonlicensees. The re-
maining members are pharmacists, five of 
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whom must be active practitioners. All are 
appointed for four-year terms. 
■ MAJOR PROJECTS 
Board Proposes Fee Increases, Cita-
tion and Fine System. On August 20, the 
Board published notice of its intent to 
amend sections 1749 and 1793.5, Title 16 
of the CCR, which specify the schedule of 
fees and late penalties prescribed by Cali-
fornia Pharmacy Law for the licenses, per-
mits, and registrations which the Board 
issues. The proposed amendments would 
raise specified fees, including pharmacy 
and pharmacist biennial renewal fees; ac-
cording to the Board, the fee increase is 
necessary to restore the Board's reserve 
fund and maintain it at a prudent level to 
enable it to conduct ongoing operations. 
At this writing, the Board is scheduled to 
conduct a public hearing on the proposed 
fee increases at its October 6 meeting in 
La Jolla. 
Also on August 20, the Board pub-
lished notice of its intent to add new Arti-
cle 9.5, commencing with section 1775, to 
Title 16 of the CCR. Specifically, the pro-
posed new article would authorize the 
Board's Executive Officer to issue cita-
tions containing orders of abatement and 
fines for violations of specified provisions 
oflaw; specify the content of a citation and 
the mode of service upon a licensee; set 
forth a scheduled of fines ranging from a 
minimum of $ I 00 to a maximum of 
$2,500 for violations of specified provis-
ions of the Business and Professions 
Code; authorize the Executive Officer to 
issue citations, assess fines, and issue or-
ders of abatement against persons who 
have performed services for which licen-
sure by the Board is required, but who lack 
a license; and set forth procedures for con-
testing or appealing any citation, order of 
abatement, or fine. At this writing, the 
Board is scheduled to conduct a public 
hearing on the proposed citation and fine 
regulations on October 6 in La Jolla. 
Rulemaking Update. The following 
is an update on rulemaking proposals dis-
cussed in detail in previous issues of the 
Reporter: 
• On May 28, the Board published no-
tice of its intent to amend section 1732.3, 
Title 16 of the CCR, regarding the dura-
tion of its approval of continuing educa-
tion (CE) courses. Specifically, the pro-
posed change would provide that a recog-
nized CE provider's coursework shall be 
valid for three years following the initial 
Board approval; currently, such course-
work is valid for two years following ini-
tial Board approval. This change would 
conform the Board's CE course validity 
period to that used by the American Coun-
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cil on Pharmaceutical Education. [13:2&3 
CRLR 101] On July 21, the Board con-
ducted a public hearing on the proposed 
change; following the hearing, the Board 
unanimously adopted the amendment, 
which awaits review and approval by the 
Office of Administrative Law (OAL). 
• On May 28, the Board published notice 
of its intent to amend section I 7 I 7(a), Title 
16 of the CCR, which provides that-with 
specified exceptions-no medication shall 
be dispensed on prescription except in a new 
container which conforms with standards 
established in the official compendia; the 
Board's proposed amendment would allow 
pharmacists to refill a prescription for non-
liquid oral products in a clean, safe container 
previously provided for the same patient for 
the same drug, provided a new label is se-
curely attached to the container. [ 13:2&3 
CRLR 101 ]On July 21, the Board conducted 
a public hearing on the proposed change; 
during the hearing, staff noted that a com-
ment submitted by the U.S. Consumer Prod-
uct Safety Commission stated that federal 
law does not allow the reuse of child-resis-
tant packaging or containers; the Board dis-
cussed whether consumers should have the 
option of reusing a prescription vial regard-
less of whether it is child-resistant. Follow-
ing discussion, the Board agreed to defer the 
regulation until its October meeting to allow 
Deputy Attorney General William Marcus 
time to inquire about the limitation of federal 
law and regulations. However, the Board 
modified the proposed language to provide 
that a pharmacy may, at the request of the 
patient or his/her agent, reuse prescription 
containers under the circumstances described 
above, provided the container is not a child-
resistant container; the Board directed staff to 
release the modified language for an addi-
tional fifteen-day public comment period. 
Legislature Approves Board's Pro-
posal to Enhance Enforcement Unit. At 
the Board's July 21 meeting, Executive 
Officer Patricia Harris reported that the 
legislature, in the state's 1993-94 budget 
bill, augmented the Board's budget by 
$705,000 to enable it to enhance its en-
forcement unit by hiring five new inspec-
tors, one supervising inspector, one con-
sumer services representative, and one 
consumer assistance technician. [ 13:2&3 
CRLR 100; 13:1 CRLR 60] 
Board Holds Enforcement Workshop, 
Revises Complaint Disclosure Policy. The 
Board devoted its entire July 22 meeting to 
an enforcement workshop. Among other 
things, the Board heard a presentation by 
Judge Karl Engeman, Director of the Office 
of Administrative Hearings (OAH), who 
discussed the disciplinary hearing process 
and the role of the OAH administrative law 
judges who preside over those hearings and 
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their use of the Board's disciplinary guide-
lines. Judge Engeman noted that disciplin-
ary guidelines are recommendations, not 
mandatory penalties, especially inasmuch 
as they have not been adopted as regula-
tions pursuant to the Administrative Pro-
cedure Act rulemaking process. OAH 
AUs use them in proposing disciplinary 
decisions, but each case is different and 
the judge must consider aggravating and 
mitigating circumstances in recommend-
ing appropriate penalties. 
Also at the enforcement workshop, the 
Board agreed to revise its existing policy 
regarding the disclosure of complaint and 
other enforcement information to inquir-
ing consumers. Under the Board's revised 
policy, the Board will provide, upon writ-
ten request, a written summary of the dis-
position of any complaint it has received 
which is substantiated and within its juris-
diction. The Board will provide the re-
questing party with the date the complaint 
was received, a synopsis of the complaint 
(e.g., prescription error, label error, unpro-
fessional conduct), and its disposition (e.g., 
referral for formal disciplinary action, dis-
missal of minor violations not meriting dis-
ciplinary action, and/or technical or practice 
act violations resolved through non-
disciplinary actions). In response to tele-
phone inquiries, the Board will provide an 
oral summary of the number of substantiated 
complaints against a licensee. Formal Board 
disciplinary actions (accusations and deci-
sions) are a matter of public record, as are 
the names of licensees, license numbers, 
address of record, date of original license, 
and current license status. 
Finally, the Board decided to proceed 
with the rulemaking process to adopt reg-
ulations to implement its citation and fine 
authority (see above). 
■ LEGISLATION 
SB 842 (Presley), as amended July 14, 
permits the Board to issue interim orders 
of suspension and other license restric-
tions, as specified, against its licensees. 
This bill was signed by the Governor on 
October 5 (Chapter 840, Statutes of 1993). 
AB 2099 (Epple). The Pharmacy Law 
prohibits a pharmacist from dispensing 
any prescription except in a container cor-
rectly labeled with certain types of infor-
mation. As amended April 28, this bill 
additionally requires the container label to 
identify the condition for which the drug 
was prescribed if the patient requests it 
and the prescription identifies the condi-
tion. This bill was signed by the Governor 
on September 8 (Chapter 397, Statutes of 
1993). 
AB 2155 (Polanco). Existing law re-
quires prescription blanks in triplicate to 
be issued by the Department of Justice 
(DOJ) and furnished to any practitioner 
authorized to write a prescription for 
Schedule II controlled substances. Exist-
ing law prohibits DOJ from issuing more 
than 100 triplicate prescription blanks to 
any authorized practitioner. As amended 
September 7, this bill would have estab-
lished, until January I, 1997, the Ad Hoc 
Committee on Prescription Pain Manage-
ment to begin a dialogue among the Attor-
ney General, various state boards (includ-
ing the Board of Pharmacy), and other 
interested persons focusing on identifying 
appropriate procedures and techniques for 
the management of acute, chronic, or in-
tractable pain, and to study various issues 
involving the treatment of pain and report 
to the Governor, the Attorney General, 
various state boards, and the legislature. 
This bill was vetoed by the Governor on 
October 8. 
SB 432 (Greene). Existing law gener-
ally requires every prescription for a 
Schedule II controlled substance to be in 
writing. However, when failure to issue a 
prescription for a Schedule II controlled 
substance to a patient in a licensed skilled 
nursing facility, an intermediate care facil-
ity, or a licensed home health agency pro-
viding hospice care would, in the opinion 
of the prescriber, present an immediate 
hazard to the patient's health and welfare 
or result in intense pain and suffering to 
the patient, the prescription may be dis-
pensed upon an oral prescription. As 
amended July 2, this bill instead provides 
that any order for a Schedule II controlled 
substance in a licensed skilled nursing 
facility, intermediate health care facility, 
or a licensed home health agency provid-
ing hospice care may be dispensed upon 
an oral prescription. 
Existing law provides that, upon re-
quest, a skilled nursing facility, intermedi-
ate care facility, or licensed home health 
agency providing hospice care shall make 
available to the dispensing pharmacist 
copies of signed telephone orders, chart 
orders, or related documentation substan-
tiating an oral prescription transaction. 
This bill instead provides that a skilled 
nursing facility, intermediate care facility, 
or licensed home health agency providing 
hospice care shall forward to the dispens-
ing pharmacist a copy of any signed tele-
phone order, chart order, or related docu-
mentation substantiating each oral pre-
scription transaction. This bill was signed 
by the Governor on July 30 (Chapter 245, 
Statutes of 1993). 
SB 1051 (McCorquodale). The Phar-
macy Law requires a pharmacist to inform 
a patient orally or in writing of the harmful 
effects of a drug dispensed by prescription 
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if the drug poses a substantial risk to the 
person consuming the drug when taken in 
combination with alcohol or if the drug 
may impair a person's ability to drive a 
motor vehicle, whichever is applicable, 
and the Board determines that the drug 
requires the warning. The Pharmacy Law 
requires any pharmacy located outside 
this state that ships, mails, or delivers any 
controlled substances or dangerous drugs 
or devices into this state pursuant to a 
prescription to register with the Board, 
disclose information regarding the phar-
macy to the Board, and meet other condi-
tions. Under the Pharmacy Law, one of 
those conditions is the requirement that 
the pharmacy, within a prescribed time 
period, provide toll-free telephone service 
to facilitate communication between pa-
tients in this state and a pharmacist at the 
pharmacy who has access to the patient's 
records. It also requires the toll-free num-
ber to be disclosed on a label affixed to 
each container of drugs dispensed to pa-
tients in this state. As amended August 16, 
this bill requires the Board to adopt spec-
ified regulations that apply the same re-
quirements or standards for oral consulta-
tion to out-of-state pharmacies that ship, 
mail, or deliver controlled substances or 
dangerous drugs or devices to residents of 
this state, as are applied to in-state phar-
macies when the pharmacy ships, mails, 
or delivers any controlled substances or 
dangerous drugs or devices to residents of 
this state. This bill was signed by the Gov-
ernor on October 2 (Chapter 763, Statutes 
of 1993). 
AB 260 (W. Brown), as amended 
April 12, and SB 1048 (Watson), as intro-
duced March 5, would establish the Clean 
Needle and Syringe Exchange Pilot Proj-
ect, and authorize pharmacists, physi-
cians, and certain other persons to furnish 
hypodermic needles and syringes without 
a prescription or permit as prescribed 
through the pilot project. Governor Wil-
son vetoed AB 260 on October 8, and SB 
1048 is a two-year bill. [S. Floor] 
AB 667 (Boland). The Pharmacy Law 
regulates the use, sale, and furnishing of 
dangerous drugs and devices, as defined; 
the law prohibits a person from furnishing 
any dangerous device, except upon the 
prescription of a physician, dentist, podi-
atrist, or veterinarian. However, existing 
law provides that this prohibition does not 
apply to the furnishing of any dangerous 
device by a manufacturer, wholesaler, or 
pharmacy to each other or to a physician, 
dentist, podiatrist, veterinarian, or physi-
cal therapist acting within the scope of 
his/her license under sales and purchase 
records that correctly give the date, the 
names and addresses of the supplier and 
the buyer, the device, and its quantity. As 
amended March 29, this bill would pro-
vide that the prohibition also does not 
apply to the furnishing of any dangerous 
device by a manufacturer, wholesaler, or 
pharmacy to a chiropractor acting within 
the scope of his/her license. 
Existing law authorizes a medical de-
vice retailer to dispense, furnish, transfer, 
or sell a dangerous device only to another 
medical device retailer, a pharmacy, a li-
censed physician, a licensed health care 
facility, a licensed physical therapist, or a 
patient or his/her personal representative. 
This bill would additionally authorize a 
medical device retailer to dispense, fur-
nish, transfer, or sell a dangerous device 
to a licensed chiropractor. [A. Health] 
SB 849 (Bergeson). Under the Phar-
macy Law, a "hospital pharmacy" means 
and includes a pharmacy licensed by the 
Board of Pharmacy located within any 
hospital, institution, or establishment that 
maintains and operates organized inpa-
tient facilities for the diagnosis, care, and 
treatment of human illnesses in accor-
dance with certain requirements. Existing 
law requires the Department of Health 
Services to issue a single consolidated li-
cense to a general acute care hospital that 
meets certain requirements. As amended 
June I, this bill would instead define a 
"hospital pharmacy" to mean a pharmacy 
licensed by the Board and located either 
within the physical plant of a general acute 
care hospital, as defined, acute psychiatric 
hospital, as defined, or special hospital, as 
defined, or outside of the hospital in an-
other physical plant that is regulated under 
the hospital's single consolidated license, 
in accordance with certain requirements. 
[A. Health] 
AB 1807 (Bronshvag), as amended 
September 8, would provide that, notwith-
standing specified security measures, a 
medical device retailer could establish a 
locked facility for furnishing dangerous 
devices in emergencies or after working 
hours, and would allow the Board to au-
thorize revisions in the security measures 
pertaining to the delivery of dangerous 
devices from locked storage to patients. 
Existing law defines the term "pre-
scription" for the purposes of existing law 
relating to licensure of pharmacists, regu-
lation of pharmacies, and regulation of 
controlled substances. This bill would re-
vise the definition of the term prescription, 
for those purposes, to also include elec-
tronically transmitted prescriptions, as de-
fined. [ 13:2&3 CRLR 100-01] 
This bill would also provide that any 
order for a Schedule II controlled sub-
stance in a licensed skilled nursing facil-
ity, intermediate health care facility, or a 
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licensed home health agency providing 
hospice care may be dispensed upon an 
oral or electronically transmitted prescrip-
tion; and would require these facilities to 
forward to the dispensing pharmacist a 
copy of any signed telephone order, chart 
order, or related documentation substanti-
ating each oral prescription transaction. 
[A. inactive File] 
SB 1153 (Watson), as amended Septem-
ber 3, is no longer relevant to the Board. 
AB 2020 (Isenberg), as amended June 
17, would, among other things, authorize 
optometrists to use, prescribe, and dispense 
specified pharmaceutical compounds to a 
patient; provide that any use, prescribing, or 
dispensing of a pharmaceutical agent to a 
patient by an optometrist pursuant to these 
provisions is limited to that which is inciden-
tal to the practice of optometry; specify that 
dispensing by the optometrist to a patient be 
without charge; and make it a misdemeanor 
for any person licensed as an optometrist to 
refer a patient to a pharmacy that is owned 
by that licensee or in which the licensee has 
proprietary interest. [S. B&PJ 
SB 1136 (Kelley). Existing law sets 
forth the requirements pursuant to which 
the Department of Health Services (DHS) 
may include a new single-source drug on 
the list of contract drugs purchased under 
the Medi-Cal program. Among other things, 
manufacturers are required to request inclu-
sion on the list within 12 months of federal 
approval for marketing of the drug, and 
DHS is required to evaluate the request 
within 90 days of its receipt. In addition, 
DHS must have concluded contracting for 
the therapeutic category in which the drug 
is included prior to federal approval of the 
drug. Existing law requires recommenda-
tions to be made on the inclusion of drugs 
on the list by the Medi-Cal Contract Drug 
Advisory Committee. As amended Sep-
tember 7, this bill would instead require 
manufacturers to request inclusion on the 
list within 18 months of federal approval, 
and require DHS to submit the drug to the 
Medi-Cal Contract Drug Advisory Com-
mittee. This bill was signed by the Gover-
nor on October 11 (Chapter 1161, Statutes 
of 1993). 
■ LITIGATION 
Huggins v. Longs Drug Stores Califor-
nia, Inc., No. S03071 l, is still pending be-
fore the California Supreme Court; the phar-
macy is appealing the Fifth District Court of 
Appeal's ruling that a pharmacist's provision 
of incorrect dosage amounts for a prescrip-
tion which the pharmacist knew or should 
have known would be administered to an 
infant by the infant's parents constitutes neg-
ligent action by the pharmacist directed at 
the parent caregivers, which may allow and 
81 
82 
REGULATORY AGENCY ACTION 
gave the parent caregivers to recover dam-
ages for negligent infliction of emotional 
distress. [ 13: 1 CRLR 63] 
At this writing, oral argument is sched-
uled for October 14 in Californians for 
Safe Prescriptions v. California State 
Board of Pharmacy, No. B073104, pend-
ing in the Second District Court of Appeal. 
The trial court held that the Board fol-
lowed and complied with the Administra-
tive Procedure Act in promulgating and 
adopting its pharmacy technician regula-
tions; plaintiffs/appellants are members of 
a nonprofit organization consisting of ap-
proximately 5,000 licensed pharmacists. 
[ 13:1 CRLR 62] 
■ RECENT MEETINGS 
At its July 21 meeting, the Board dis-
cussed a proposal for amending section 
I 751.10, Title 16 of the CCR, to allow 
licensed pharmacies which are also li-
censed as home health agencies to dis-
pense emergency kits to home health 
agency registered nurses who provide care 
to patients in their homes; staff noted that 
escalating health care costs have resulted 
in patients being released earlier from hos-
pitals for convalescence at home. This 
proposal would allow home health agency 
registered nurses to carry an emergency 
kit with stock items upon a written or oral 
prescription; the provisions would call for 
a locked, portable unit with only specified 
drugs and a method for inventory control. 
Following discussion, the Board directed 
its Executive Officer to draft appropriate 
regulatory language; the Board expects to 
hold a public hearing on the proposal in 
January or April. 
Also in July, Board President Steve 
Dibble recommended that the Board ask 
the Drug Enforcement Agency (DEA) for 
clarification regarding 21 C.F.R. section 
1304.04, which requires pharmacists to 
stamp a red "C" on the hard copy of con-
trolled substance prescriptions; Dibble 
noted that such a requirement is unneces-
sary if the pharmacy is computerized. The 
Board agreed to ask DEA to allow phar-
macies to either maintain a separate elec-
tronic file of Schedule III-V controlled 
substances, or maintain a separate physi-
cal file of Schedule III-V controlled sub-
stances, or mark all Schedule III-V con-
trolled substance prescriptions with a red 
"C." 
Also at its July meeting, the Board 
unanimously agreed to seek amendments 
to Business and Professions Code section 
400 I to provide that at least one pharma-
cist position on the Board shall be filled 
by a pharmacist who actively dispenses 
prescriptions in the community or outpa-
tient pharmacy setting. 
Finally, the Board elected its 1993-94 
officers at the July meeting: Raffi Simon-
ian will serve as President, Janeen McBr-
ide was elected Vice-President, and M. 
Standifer Shreve was chosen as Treasurer. 
■ FUTURE MEETINGS 
January 26-27 (location to be 
announced). 
April 27-28 (location to be announced). 







Harold L. Turner 
(916) 263-2222 
The Board of Registration for Profes-sional Engineers and Land Surveyors 
(PELS) regulates the practice of engineer-
ing and land surveying through its admin-
istration of the Professional Engineers 
Act, sections 6700 through 6799 of the 
Business and Professions Code, and the 
Professional Land Surveyors' Act, sec-
tions 8700 through 8805 of the Business 
and Professions Code. The Board's regu-
lations are found in Division 5, Title 16 of 
the California Code of Regulations (CCR). 
The basic functions of the Board are to 
conduct examinations, issue certificates, 
registrations, and/or licenses, and appro-
priately channel complaints against regis-
trants/licensees. The Board is additionally 
empowered to suspend or revoke registra-
tions/licenses. The Board considers the 
proposed decisions of administrative law 
judges who hear appeals of applicants 
who are denied a registration/license, and 
those who have had their registration/li-
cense suspended or revoked for violations. 
The Board consists of thirteen mem-
bers: seven public members, one licensed 
land surveyor, four registered Practice Act 
engineers and one Title Act engineer. 
Eleven of the members are appointed by 
the Governor for four-year terms which 
expire on a staggered basis. One public 
member is appointed by the Speaker of the 
Assembly and one by the Senate Rules 
Committee. 
The Board has established four stand-
ing committees and appoints other special 
committees as needed. The four standing 
committees are Administration, Enforce-
ment, Examination/Qualifications, and 
Legislation. The committees function in 
an advisory capacity unless specifically 
authorized to make binding decisions by 
the Board. 
Professional engineers are registered 
through the three Practice Act categories 
of civil, electrical, and mechanical engi-
neering under section 6730 of the Busi-
ness and Professions Code. The Title Act 
categories of agricultural, chemical, con-
trol system, corrosion, fire protection, in-
dustrial, manufacturing, metallurgical, 
nuclear, petroleum, quality, safety, and 
traffic engineering are registered under 
section 6732 of the Business and Profes-
sions Code. 
Structural engineering and geotechni-
cal engineering are authorities linked to 
the civil Practice Act and require an addi-
tional examination after qualification as a 
civil engineer. 
On June 15, three new Board members 
were appointed to replace members whose 
terms had expired. Megan Matthews, the 
owner of Matthews Land Company in 
Santa Cruz, replaced George Warriner as 
a public member; Myrna Powell, the co-
ordinator of the CALL-3 Consumer Ac-
tion Program at KCRA-TV in Sacra-
mento, replaced Bill Rupp as a public 
member; and Quang Vu, a mechanical en-
gineer and president of Dahl, Taylor and 
Associates, Inc., in Newport Beach, re-
placed Bob Young as a Practice Act engi-
neer member. The terms of the three new 
members expire on June I, 1996. 
■ MAJOR PROJECTS 
Board Approves New Examination 
Administration. At the Board's August 
27 meeting, the Examination/Qualifica-
tion Committee presented its findings and 
recommendations regarding a proposal 
that PELS develop and administer its own 
Special Four examinations (corrosion, 
quality, safety, and traffic) in-house as a 
cost-saving measure. [ 13:2&3 CRLR 
104] Among other things, the Committee 
noted that the Board currently develops 
and administers the structural engineering 
examination using its own resources and 
expertise; according to the Committee, the 
Board could use that expertise to develop 
and administer the Special Four exams 
and achieve a cost savings of approxi-
mately $23,000 per year. The Committee 
reported that in-house development and 
administration would allow the Board 
more control and flexibility over the ex-
aminations, and could allow it to explore 
options such as on-demand testing or 
computer-generated examinations. The 
Committee noted that the disadvantage of 
developing and administering the exami-
nations in-house is that 40% of one staff 
member's time would be required to coor-
dinate the examinations. 
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